This is a StreetInsider.com Premium Only Page

American Virtual Cloud Technologies (AVCT) – Business Wire

Jun 21, 2023 04:29 AM Avacta Announces Successful Completion of Fifth Dose Escalation in AVA6000 Phase 1 Clinical Study

Apr 27, 2023 07:00 AM First Patient Dosed in the US in Avacta’s AVA6000 Phase 1 Clinical Study

Apr 5, 2023 03:59 AM Avacta Announces First Patient Dosed in Fifth Cohort of AVA6000 Phase Ia Dose Escalation Study

Mar 28, 2023 05:57 AM Avacta Appoints Karen Harrison as Chief Operating Officer for Therapeutics Division

Sep 5, 2022 04:56 AM Avacta Announces AVA6000 Receives Orphan Drug Designation From the US Food and Drug Administration

Jun 30, 2022 05:11 AM LG Chem Renews License Triggering Payment to Avacta

Apr 13, 2022 04:42 AM Avacta Announces AffyXell Joint Venture Milestone and Increased Equity Stake

Mar 21, 2022 06:15 AM Avacta Appoints Dr Christina Coughlin as Non-Executive Director

Jan 18, 2022 04:20 AM Avacta Selects Second pre|CISION™ Pro-drug Candidate for Development

Dec 22, 2021 04:12 AM Avacta Announces AffiDX® SARS-CoV-2 Antigen Lateral Flow Test Receives CE Mark for Consumer Self-Testing

Dec 15, 2021 04:48 AM Avacta Announces AffiDx® SARS-CoV-2 Antigen Lateral Flow Test Detects the Omicron Variant

Nov 29, 2021 03:53 AM Avacta Announces FDA Approval of its Investigational New Drug (IND) Application for AVA6000

Aug 11, 2021 04:47 AM Avacta Announces First Patient Dosed in AVA6000 Pro-Doxorubicin Phase I Clinical Trial

Jul 14, 2021 04:16 AM Avacta’s Diagnostic Division Achieves ISO 13485 Certification

Jun 29, 2021 05:36 AM Avacta Announces AffiDX® SARS-CoV-2 Antigen Lateral Flow Test Detects Delta Variant

Jun 21, 2021 04:56 AM Avacta Announces AffiDX® SARS-CoV-2 Antigen Lateral Flow Test Distribution Agreement

Jun 11, 2021 07:25 AM Avacta Announces Registration of its AffiDX SARS-CoV-2 Antigen Lateral Flow Test in EU

Jun 7, 2021 03:51 AM MHRA Confirms Registration of Avacta’s AffiDX® SARS-CoV-2 Antigen Lateral Flow Test

May 20, 2021 07:00 AM Cisco and AVCT Join Student Freedom Initiative, Expanding Strategic Partnership to Address Student Loan Debt and Modernize Digital Infrastructure at all HBCUs

Apr 20, 2021 05:48 AM Avacta Receives Clinical Validation of AffiDX SARS-CoV-2 Antigen Lateral Flow Test

Apr 6, 2021 06:21 AM Avacta Announces Distribution Agreement With ABCAM plc

Mar 8, 2021 02:30 AM Avacta’s Rapid Antigen Test Is Confirmed to Detect SARS-CoV-2 New Variants

Mar 4, 2021 09:15 AM Computex Named to the 2021 Elite 150 in CRN® MSP 500 List

Feb 18, 2021 03:05 AM Avacta Announces Phase 1 Clinical Trial Authorisation (CTA) for AVA6000 Approved by MHRA

Feb 8, 2021 03:59 AM Avacta and Mologic Announce Commercial Partnership

Feb 1, 2021 12:09 PM Avacta announces AffyXell $7.3 Million Series A Financing

Jan 28, 2021 04:19 AM Avacta Announces Collaboration Agreement With Bruker

Jan 11, 2021 09:30 AM Navigation Capital Partners SPAC Operations Significantly Expands SPAC Portfolio

Jan 7, 2021 03:49 AM Avacta Announces License Agreement With POINT Biopharma Inc.

Dec 23, 2020 03:45 AM Avacta Submits Clinical Trial Application for AVA6000 pro-doxorubixin

Dec 21, 2020 03:50 AM Avacta Group plc Signs License Agreement With Astrea Bioseparations

Sep 30, 2020 07:20 AM Avacta Launches SARS-CoV-2 BAMS Research Test

Sep 2, 2020 03:56 AM Avacta Expands Rapid SARS-CoV-2 Antigen Test Manufacturing Capacity

Aug 18, 2020 04:06 AM Avacta and LG Chem Life Sciences Expand Partnership

Aug 11, 2020 04:05 AM Avacta Appoints Therapeutics Chief Development Officer

Aug 7, 2020 04:47 AM Avacta Announces SARS-CoV-2 Rapid Antigen Test Clinical Collaboration

Aug 6, 2020 04:16 AM Avacta Appoints COVID-19 Rapid Antigen Test Manufacturing Partner

Jul 29, 2020 05:00 AM Avacta and Daewoong Pharmaceutical expand partnership to include COVID-19 neutralising Affimer therapy

Jul 22, 2020 04:29 AM Avacta provides update on clinical validation of Adeptrix COVID-19 diagnostic test

Jul 13, 2020 04:40 AM Avacta and Integumen plc collaborate for detection of SARS-COV-2 coronavirus in waste water

Jun 24, 2020 03:49 AM Avacta Provides Update on COVID-19 Rapid Antigen Test Development Partnership With Cytiva

Jun 18, 2020 03:58 AM Avacta provides update on Affimer therapy for COVID-19 infection

Jun 9, 2020 04:06 AM Avacta Provides Update on COVID-19 Antigen Diagnostic Test Development With Adeptrix

May 20, 2020 03:50 AM Avacta and Medusa19 Enter Into a Distribution Agreement For COVID-19 Antigen Test

May 15, 2020 04:19 AM Avacta Develops SARS-COV-2 Neutralising Affimer Reagents with Therapeutic Potential for COVID-19

May 11, 2020 12:38 PM Avacta Ships SARS-COV-2 Affimer Reagents to Cytiva and Adeptrix

May 1, 2020 04:13 AM Avacta Group plc Forms COVID-19 Antigen Diagnostic Collaboration With Adeptrix

Apr 27, 2020 11:12 AM Navigation Capital Partners’ Portfolio Company Computex Sold to American Virtual Cloud Technologies

Apr 22, 2020 04:02 AM Avacta Successfully Generates Several Highly Specific Affimer Reagents for COVID-19 Antigen Rapid Test Ahead of Schedule as Part of Cytiva Partnership

Apr 8, 2020 04:13 AM Avacta and Cytiva Collaborating on COVID-19 Rapid Test